These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37726739)

  • 1. Influence of complement protein C1q or complement receptor C5aR1 on gut microbiota composition in wildtype and Alzheimer's mouse models.
    Petrisko TJ; Gargus M; Chu SH; Selvan P; Whiteson KL; Tenner AJ
    J Neuroinflammation; 2023 Sep; 20(1):211. PubMed ID: 37726739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.
    Hernandez MX; Jiang S; Cole TA; Chu SH; Fonseca MI; Fang MJ; Hohsfield LA; Torres MD; Green KN; Wetsel RA; Mortazavi A; Tenner AJ
    Mol Neurodegener; 2017 Sep; 12(1):66. PubMed ID: 28923083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C5aR1 signaling promotes region- and age-dependent synaptic pruning in models of Alzheimer's disease.
    Gomez-Arboledas A; Fonseca MI; Kramar E; Chu SH; Schartz ND; Selvan P; Wood MA; Tenner AJ
    Alzheimers Dement; 2024 Mar; 20(3):2173-2190. PubMed ID: 38278523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C5aR1 antagonism alters microglial polarization and mitigates disease progression in a mouse model of Alzheimer's disease.
    Gomez-Arboledas A; Carvalho K; Balderrama-Gutierrez G; Chu SH; Liang HY; Schartz ND; Selvan P; Petrisko TJ; Pan MA; Mortazavi A; Tenner AJ
    Acta Neuropathol Commun; 2022 Aug; 10(1):116. PubMed ID: 35978440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of C5a-C5aR1 signaling alters the dynamics of AD progression.
    Carvalho K; Schartz ND; Balderrama-Gutierrez G; Liang HY; Chu SH; Selvan P; Gomez-Arboledas A; Petrisko TJ; Fonseca MI; Mortazavi A; Tenner AJ
    J Neuroinflammation; 2022 Jul; 19(1):178. PubMed ID: 35820938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Analysis of the Microbiome and Metabolome in the 5xfAD Mouse Model of Alzheimer's Disease.
    Dunham SJB; McNair KA; Adams ED; Avelar-Barragan J; Forner S; Mapstone M; Whiteson KL
    mBio; 2022 Dec; 13(6):e0179422. PubMed ID: 36468884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer's disease.
    Zhou J; Fonseca MI; Pisalyaput K; Tenner AJ
    J Neurochem; 2008 Sep; 106(5):2080-92. PubMed ID: 18624920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer's disease mouse model.
    Schartz ND; Liang HY; Carvalho K; Chu SH; Mendoza-Arvilla A; Petrisko TJ; Gomez-Arboledas A; Mortazavi A; Tenner AJ
    Nat Commun; 2024 Aug; 15(1):7028. PubMed ID: 39147742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease.
    Fonseca MI; Chu SH; Berci AM; Benoit ME; Peters DG; Kimura Y; Tenner AJ
    J Neuroinflammation; 2011 Jan; 8(1):4. PubMed ID: 21235806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patchouli alcohol attenuates the cognitive deficits in a transgenic mouse model of Alzheimer's disease via modulating neuropathology and gut microbiota through suppressing C/EBPβ/AEP pathway.
    Xu QQ; Su ZR; Yang W; Zhong M; Xian YF; Lin ZX
    J Neuroinflammation; 2023 Jan; 20(1):19. PubMed ID: 36717922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C5aR1 antagonism suppresses inflammatory glial gene expression and alters cellular signaling in an aggressive Alzheimer's model.
    Schartz ND; Liang HY; Carvalho K; Chu SH; Mendoza-Arvilla A; Petrisko TJ; Gomez-Arboledas A; Mortazavi A; Tenner AJ
    bioRxiv; 2023 Aug; ():. PubMed ID: 37662399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-specific associations between AD genotype and the microbiome of human amyloid beta knock-in (hAβ-KI) mice.
    Dunham SJB; Avelar-Barragan J; Rothman JA; Adams ED; Faraci G; Forner S; Kawauchi S; Tenner AJ; Green KN; LaFerla FM; MacGregor GR; Mapstone M; Whiteson KL
    Alzheimers Dement; 2024 Jul; 20(7):4935-4950. PubMed ID: 38572865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental colitis in young Tg2576 mice accelerates the onset of an Alzheimer's-like clinical phenotype.
    Lorenzini L; Zanella L; Sannia M; Baldassarro VA; Moretti M; Cescatti M; Quadalti C; Baldi S; Bartolucci G; Di Gloria L; Ramazzotti M; Clavenzani P; Costanzini A; De Giorgio R; Amedei A; Calzà L; Giardino L
    Alzheimers Res Ther; 2024 May; 16(1):116. PubMed ID: 38773640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer's disease.
    Fonseca MI; Zhou J; Botto M; Tenner AJ
    J Neurosci; 2004 Jul; 24(29):6457-65. PubMed ID: 15269255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglial C5aR (CD88) expression correlates with amyloid-beta deposition in murine models of Alzheimer's disease.
    Ager RR; Fonseca MI; Chu SH; Sanderson SD; Taylor SM; Woodruff TM; Tenner AJ
    J Neurochem; 2010 Apr; 113(2):389-401. PubMed ID: 20132482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial sepsis increases hippocampal fibrillar amyloid plaque load and neuroinflammation in a mouse model of Alzheimer's disease.
    Basak JM; Ferreiro A; Cohen LS; Sheehan PW; Nadarajah CJ; Kanan MF; Sukhum KV; Dantas G; Musiek ES
    Neurobiol Dis; 2021 May; 152():105292. PubMed ID: 33556539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting Neurodegenerative Disease Using Prepathology Gut Microbiota Composition: a Longitudinal Study in Mice Modeling Alzheimer's Disease Pathologies.
    Borsom EM; Conn K; Keefe CR; Herman C; Orsini GM; Hirsch AH; Palma Avila M; Testo G; Jaramillo SA; Bolyen E; Lee K; Caporaso JG; Cope EK
    Microbiol Spectr; 2023 Mar; 11(2):e0345822. PubMed ID: 36877047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota regulate Alzheimer's disease pathologies and cognitive disorders via PUFA-associated neuroinflammation.
    Chen C; Liao J; Xia Y; Liu X; Jones R; Haran J; McCormick B; Sampson TR; Alam A; Ye K
    Gut; 2022 Nov; 71(11):2233-2252. PubMed ID: 35017199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a humanized C1q A chain knock-in mouse: assessment of antibody independent beta-amyloid induced complement activation.
    Li M; Ager RR; Fraser DA; Tjokro NO; Tenner AJ
    Mol Immunol; 2008 Jun; 45(11):3244-52. PubMed ID: 18400300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terminal complement pathway activation drives synaptic loss in Alzheimer's disease models.
    Carpanini SM; Torvell M; Bevan RJ; Byrne RAJ; Daskoulidou N; Saito T; Saido TC; Taylor PR; Hughes TR; Zelek WM; Morgan BP
    Acta Neuropathol Commun; 2022 Jul; 10(1):99. PubMed ID: 35794654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.